Hanwei Technology (920957) receives research visits from multiple institutions; the raised-capital investment projects enter a key period for capacity release

robot
Abstract generation in progress

Hanwei Technology (920957) received on-site visits and research from CITIC Capital, the Shenzhen Chamber of Commerce General Chamber, the Guangxi-Guangdong company, and other individual investors on March 31, 2026. The company’s board secretary, Feng Miao, and the person in charge of finance, Chen Lianghua, participated in this reception, and responded to questions raised by investors regarding the progress of the fundraising and investment (募投) projects they are interested in, the schedule for capacity release, product structure, and the company’s layout in emerging areas.

Regarding the fundraising and investment project situation, the company stated that some new products, such as fatty acid ester, were officially put into production on February 6, 2025. In 2026, the fundraising and investment projects will begin entering the key stage for capacity release. The company will gradually release capacity in accordance with industry market conditions, and expects that all capacity will be released within the next five years. The company also pointed out that in the short term, before the fundraising and investment projects have fully reached production capacity, the increase in depreciation expenses, resource reserve expenses, and related administrative expenses will put short-term pressure on capacity absorption, and the company’s performance will be temporarily under pressure.

Regarding product structure and application areas, the company introduced that its products are mainly used as heat stabilizers, lubricants, grinding aids, dispersants, isolating agents, and acid-absorbing agents. Specifically, they include fatty acid salt additives and composite additives. Application fields include plastics, coatings, rubber, petrochemicals, papermaking, food, pharmaceuticals, and cosmetics, among others. In response to the fact that the company’s current fatty acid salt additive has a relatively high share of revenue, the company said that downstream customers are relatively dispersed, which allows the company to better avoid risks from changes in downstream industry demand and changes in customer structure. In the future, the company will increase investment in enriching product structure, improving product performance, and expanding application areas.

With respect to its layout in emerging application areas such as new energy battery materials, the company clearly stated that its products are not directly used in emerging application areas such as new energy battery materials. The company’s largest application scenario is the plastics industry, where they are used as functional additives during the production of related plastic packaging materials, lubricating materials, and housing materials.

China Wall Finance learned that the company focuses on the research, production, and sales of environmentally friendly stearate (zinc, calcium, magnesium) series and other high-molecular polymer chemical additive products within the fine chemicals sector, and has a good reputation and stable growth among its customer base.

Relying on strong R&D capabilities, the company has obtained multiple patents and achieved industrialization. The company was among the first to adopt advanced clean automated production lines, achieving product environmentalization and production scale, optimizing product production processes, improving production efficiency, and reducing the company’s product cost, laying a solid foundation for maintaining its leading advantages in the industry and continuously obtaining stable revenue and profits.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin